Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection Anthony Fernandes / Thursday, April 22, 2021 / Article rating: 4.0 On Thursday, Caplin Point Laboratories announced that its subsidiary, Caplin Steriles Limited has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Neostigmine Methylsulfate injection.
EaseMyTrip partners with JustDial to become exclusive air travel services provider EaseMyTrip partners with JustDial to become exclusive air travel services provider Anthony Fernandes / Thursday, April 22, 2021 / Article rating: 5.0 On Thursday, Easy Trip Planners Limited informed the bourses that it has joined hands with JustDial to provide air travel services.
Best performing pension fund managers Best performing pension fund managers Henil Shah / Thursday, April 22, 2021 / Article rating: 3.5 NPS is one such investment that everyone must have, irrespective of their income. In this article, we would be revealing the best pension fund managers. So, keep reading.
This ten-bagger small-cap pharma stock just got locked in upper circuit This ten-bagger small-cap pharma stock just got locked in upper circuit Geyatee Deshpande / Thursday, April 22, 2021 / Article rating: 3.6 Pharma stocks are in vogue ever since the pandemic hit us last year. Several pharma companies have turned out to be multibaggers in the past couple of years or even in the past one year.
This wellness-related stock doubled in one month This wellness-related stock doubled in one month Geyatee Deshpande / Thursday, April 22, 2021 / Article rating: 4.2 Sensex is down by more than 2 per cent in one month even as the metal and healthcare-related stocks are buzzing on the bourses.
This low P/E stock is trading at lifetime high This low P/E stock is trading at lifetime high Geyatee Deshpande / Thursday, April 22, 2021 / Article rating: 3.8 Usually, low P/E stocks are considered attractive for investments. However, not all low P/E stocks turn out to be multibaggers. Titan Biotech is one such stock, which is trading at low P/E and is turning out to be a classic multibagger.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Ganesh Pawar / Thursday, April 22, 2021 / Article rating: 3.8 The market opened in red on April 22, 2021.
Five stocks witnessing long built-up Five stocks witnessing long built-up Ganesh Pawar / Thursday, April 22, 2021 / Article rating: 4.6 The market opened in red on April 22, 2021, overall volumes in futures & options currently stand at 4,56,59,667 contracts with a turnover of Rs. 41,71,483.21 crore.
Five stocks witnessing short built-up Five stocks witnessing short built-up Ganesh Pawar / Thursday, April 22, 2021 / Article rating: 4.0 The market opened in red on April 22, 2021, overall volumes in futures & options currently stand at 4,56,59,667 contracts with a turnover of Rs. 41,71,483.21 crore.
Upper circuit stock: Wanbury with low P/E, now on verge of breakout Upper circuit stock: Wanbury with low P/E, now on verge of breakout Shreya Chaware / Thursday, April 22, 2021 / Article rating: 3.4 Several pharma stocks are rallying and Wanbury is just another lesser-known name that is attracting investors. According to BSE website, the company is trading at a P/E of 4, with a market cap (free float) of Rs 107 crore.